Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization.

Autor: Tricot, G.1 guido.tricot@hsc.utah.edu, Cottler-Fox, M. H.2, Calandra, G.
Zdroj: Bone Marrow Transplantation. Jan2010, Vol. 45 Issue 1, p63-68. 6p. 4 Charts, 1 Graph.
Databáze: Academic Search Ultimate